The MAGEL2 gene helps brain cells, especially in areas that guide hunger, sleep, hormones, and development, handle how proteins are moved and reused inside the cell. Only one copy is usually active, so if that working copy does not function, the effects can be noticeable. People with harmful variants in the MAGEL2 gene may have low muscle tone, feeding problems, delayed development, and later differences in sleep, behavior, or weight. Disruptive variants in this gene are linked to Schaaf-Yang syndrome.
What is a gene?
A gene is a section of DNA that carries instructions your cells use to make molecules or guide processes in the body. Some genes hold the instructions for producing proteins, which are the parts of cells that do much of the work. Other genes mainly regulate when certain processes happen, where they occur, and how strongly they are carried out. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. If you want to explore this subject in more detail, you can read more in the LearnHub.
Overview
MAGEL2Gene function
What if the gene works
The MAGEL2 gene helps brain cells recycle and move proteins to the right place. This supports hypothalamus functions that help regulate hunger, hormone release, sleep, and daily body rhythms.
Risk
What if the gene does not work
When the MAGEL2 gene is not working correctly, it is linked to Schaaf-Yang syndrome, which affects muscle tone, feeding, development, joints, and behavior. Milder and more severe variants can change when features appear and how much they affect a person.
Treatment
What does that mean for your treatment
No treatment or drug choice is currently guided specifically by a pathogenic variant in the MAGEL2 gene; care is based on the person's symptoms and day to day needs. Researchers are studying targeted approaches, including oxytocin related treatments, in MAGEL2-related conditions, but these are not established standard care.
Conditions associated with MAGEL2
Gene function
What if the gene works
In the brain, the MAGEL2 gene is most active in areas that help control sleep, hunger, hormone release, and daily body rhythms. Inside cells, it helps manage how certain proteins are moved, reused, and kept in the right place. This explains much of the MAGEL2 gene's role in steady brain signaling and body timing.
The MAGEL2 gene helps cells direct certain proteins to the right place at the right time. This keeps cell surfaces and internal compartments organized for normal day to day function.
Inside your cells, the MAGEL2 gene supports endosomal recycling (the system that returns useful proteins for reuse). This helps cells keep important surface proteins available and respond smoothly to signals.
The MAGEL2 gene is especially important in brain areas that coordinate sleep, appetite, hormone release, and body timing. When it is working as expected, these control centers can communicate in a steady, organized way.
What is a variant?
A genetic variant is a minor difference in a gene’s DNA sequence. These differences are common and are part of normal human diversity, including variation in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Most disease-causing changes in the MAGEL2 gene are truncating variants on the active paternal copy that cut the protein short. Because MAGEL2 is encoded in a single stretch of DNA, the shortened protein may still be made instead of being cleared away, which helps explain how MAGEL2 variants affect protein function. The abnormal protein can disrupt its usual cell partners and protein recycling inside cells. More disruptive truncating variants often have a larger functional effect than milder changes.
How variants are linked to conditions
Pathogenic variants in the MAGEL2 gene cause Schaaf-Yang syndrome, a condition linked with low muscle tone in infancy, developmental delay, intellectual disability, autism features, and joint stiffness present from birth. Changes involving the MAGEL2 gene can also contribute to findings seen in some people with Prader-Willi syndrome because this gene lies in the same chromosome region. MAGEL2 gene variants are linked to conditions in a variable way, so symptoms and severity can differ from person to person.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely found across the general population. Most do not directly affect health and instead reflect normal human diversity. For many genes, having a variant associated with a condition points to a possible link rather than confirming a diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well-studied variant in a particular gene is enough to establish the diagnosis.
Are there things that can increase or change my risk?
For MAGEL2, risk is mainly shaped by whether there is a disease-causing change in the gene and whether it is on the copy inherited from the father, because this gene is usually active only on the paternal copy. There is not enough evidence to say that lifestyle or environmental factors meaningfully change the chance of developing a MAGEL2-related condition.
Inheritance of MAGEL2 variants
How MAGEL2 variants are inherited is a little unusual because this gene follows autosomal dominant inheritance with genomic imprinting, a parent of origin effect. In MAGEL2 related conditions such as Schaaf-Yang syndrome, a child is usually affected only if the variant is on the copy inherited from the father, because the mother’s copy is normally switched off. An affected father can pass the variant to each child with a 50% chance, while some cases happen through a new de novo variant. A mother may carry a MAGEL2 variant without symptoms and can pass it on silently.
What does my MAGEL2 result mean for my family?
For MAGEL2, family impact depends on which parent passed on the changed gene. A result is usually relevant when the altered copy comes from the father, so close relatives on the father’s side may also carry it or be affected. Some changes happen for the first time in a child, but MAGEL2 changes can also be passed through a family in this parent-specific way.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for MAGEL2 variants usually uses a blood or saliva sample, which a lab reads to look for changes in the MAGEL2 gene. Testing may be done as a single-gene test, a broader neurodevelopmental panel, or exome sequencing, and results can show whether a variant was found and how likely it is to explain symptoms.
When should I consider getting a genetic test?
Consider MAGEL2 testing when a baby or child has signs linked to Schaaf-Yang syndrome, such as very low muscle tone, feeding problems, delayed development, autism features, or tight joints. Testing can also be helpful when this condition is known in the family or a close relative carries a MAGEL2 variant.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it reveals depends on the condition and on the kind of variant involved. Over time, the way the body works is also shaped by many factors, including lifestyle, environment, age, and medical history. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, or responds to a drug, so the same treatment may work better for one person than for another. This is a common part of human biology and can influence how much benefit someone gets from a medicine or how sensitive they are to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect a person’s response to medications. It studies the relationships between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body processes it. This understanding can support more informed and personalized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the MAGEL2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so general questions about medicines, side effects, or changes in your health are best discussed with your doctor.
History
MAGEL2 entered medical genetics through research on chromosome 15, the region linked to Prader-Willi syndrome. In the 1990s, scientists studying genomic imprinting, a process where only one parent’s copy of a gene is active, recognized the MAGEL2 gene as part of this important stretch of DNA. Initially understood only through visible traits, later recognized as tied to a specific gene, its clinical relevance became clearer as sequencing improved. A major step came in the 2010s, when harmful variants in the MAGEL2 gene were identified in people with what is now called Schaaf-Yang syndrome. From these first observations, research expanded steadily. Today, MAGEL2 is best known in the history of genetics for helping connect imprinting research with rare neurodevelopmental conditions.